Calcitonin modifies ligand binding to muscarinic receptor in CNS membranes
- Autores
- Rodriguez, Georgina Emma; Schneider, Patricia Graciela
- Año de publicación
- 2000
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Calcitonin (CT) is a peptide produced by the thyroid gland, whose best described role is to prevent bone reabsorption, though it also participates in other biological functions through both central and peripheral mechanisms. CT is able to inhibit brain Na+, K+-ATPase activity (Rodriguez de Lores Arnaiz, Lopez Ordieres, Peptides 1997;18:613-5) and a relationship between such enzyme activity and cholinergic function has been suggested. Accordingly, we tested CT effect on [3H]-quinuclidinyl benzilate ([3H]-QNB) binding to rat CNS membranes to determine whether the peptide is able to modify the cholinergic muscarinic receptor as well. It was found that 1x10-7-1x10-5 M CT decreased 20-70% ligand binding to hippocampal, cerebellar, cortical and striatal membranes. Scatchard analysis of saturation curves showed that 5x10-6 M CT significantly modified binding kinetic constants, thus it increased roughly 220% Kd values and decreased 20-36% Bmax values in cerebral cortical and cerebellar membranes. Since the peptide decreases affinity ligand binding and reduces the number of binding sites, CT may well be acting as a cholinergic modulator through a decrease in muscarinic receptor functionality. © 2000 Elsevier Science B.V.
Fil: Rodriguez, Georgina Emma. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia ; Argentina
Fil: Schneider, Patricia Graciela. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia ; Argentina - Materia
-
Calcitonin Effect
Cholinergic Muscarinic Receptor
Cholinergic System
Cns Membranes
Na+, K+-Atpase
Qnb Binding
Sodium Pump - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/39154
Ver los metadatos del registro completo
id |
CONICETDig_2d2d60776af8542d14e91f591ff8922a |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/39154 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Calcitonin modifies ligand binding to muscarinic receptor in CNS membranesRodriguez, Georgina EmmaSchneider, Patricia GracielaCalcitonin EffectCholinergic Muscarinic ReceptorCholinergic SystemCns MembranesNa+, K+-AtpaseQnb BindingSodium Pumphttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Calcitonin (CT) is a peptide produced by the thyroid gland, whose best described role is to prevent bone reabsorption, though it also participates in other biological functions through both central and peripheral mechanisms. CT is able to inhibit brain Na+, K+-ATPase activity (Rodriguez de Lores Arnaiz, Lopez Ordieres, Peptides 1997;18:613-5) and a relationship between such enzyme activity and cholinergic function has been suggested. Accordingly, we tested CT effect on [3H]-quinuclidinyl benzilate ([3H]-QNB) binding to rat CNS membranes to determine whether the peptide is able to modify the cholinergic muscarinic receptor as well. It was found that 1x10-7-1x10-5 M CT decreased 20-70% ligand binding to hippocampal, cerebellar, cortical and striatal membranes. Scatchard analysis of saturation curves showed that 5x10-6 M CT significantly modified binding kinetic constants, thus it increased roughly 220% Kd values and decreased 20-36% Bmax values in cerebral cortical and cerebellar membranes. Since the peptide decreases affinity ligand binding and reduces the number of binding sites, CT may well be acting as a cholinergic modulator through a decrease in muscarinic receptor functionality. © 2000 Elsevier Science B.V.Fil: Rodriguez, Georgina Emma. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia ; ArgentinaFil: Schneider, Patricia Graciela. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia ; ArgentinaElsevier Science2000-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/39154Rodriguez, Georgina Emma; Schneider, Patricia Graciela; Calcitonin modifies ligand binding to muscarinic receptor in CNS membranes; Elsevier Science; Regulatory Peptides; 88; 1-3; 3-2000; 21-260167-0115CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1016/S0167-0115(99)00109-3info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0167011599001093info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:33:31Zoai:ri.conicet.gov.ar:11336/39154instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:33:31.487CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Calcitonin modifies ligand binding to muscarinic receptor in CNS membranes |
title |
Calcitonin modifies ligand binding to muscarinic receptor in CNS membranes |
spellingShingle |
Calcitonin modifies ligand binding to muscarinic receptor in CNS membranes Rodriguez, Georgina Emma Calcitonin Effect Cholinergic Muscarinic Receptor Cholinergic System Cns Membranes Na+, K+-Atpase Qnb Binding Sodium Pump |
title_short |
Calcitonin modifies ligand binding to muscarinic receptor in CNS membranes |
title_full |
Calcitonin modifies ligand binding to muscarinic receptor in CNS membranes |
title_fullStr |
Calcitonin modifies ligand binding to muscarinic receptor in CNS membranes |
title_full_unstemmed |
Calcitonin modifies ligand binding to muscarinic receptor in CNS membranes |
title_sort |
Calcitonin modifies ligand binding to muscarinic receptor in CNS membranes |
dc.creator.none.fl_str_mv |
Rodriguez, Georgina Emma Schneider, Patricia Graciela |
author |
Rodriguez, Georgina Emma |
author_facet |
Rodriguez, Georgina Emma Schneider, Patricia Graciela |
author_role |
author |
author2 |
Schneider, Patricia Graciela |
author2_role |
author |
dc.subject.none.fl_str_mv |
Calcitonin Effect Cholinergic Muscarinic Receptor Cholinergic System Cns Membranes Na+, K+-Atpase Qnb Binding Sodium Pump |
topic |
Calcitonin Effect Cholinergic Muscarinic Receptor Cholinergic System Cns Membranes Na+, K+-Atpase Qnb Binding Sodium Pump |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Calcitonin (CT) is a peptide produced by the thyroid gland, whose best described role is to prevent bone reabsorption, though it also participates in other biological functions through both central and peripheral mechanisms. CT is able to inhibit brain Na+, K+-ATPase activity (Rodriguez de Lores Arnaiz, Lopez Ordieres, Peptides 1997;18:613-5) and a relationship between such enzyme activity and cholinergic function has been suggested. Accordingly, we tested CT effect on [3H]-quinuclidinyl benzilate ([3H]-QNB) binding to rat CNS membranes to determine whether the peptide is able to modify the cholinergic muscarinic receptor as well. It was found that 1x10-7-1x10-5 M CT decreased 20-70% ligand binding to hippocampal, cerebellar, cortical and striatal membranes. Scatchard analysis of saturation curves showed that 5x10-6 M CT significantly modified binding kinetic constants, thus it increased roughly 220% Kd values and decreased 20-36% Bmax values in cerebral cortical and cerebellar membranes. Since the peptide decreases affinity ligand binding and reduces the number of binding sites, CT may well be acting as a cholinergic modulator through a decrease in muscarinic receptor functionality. © 2000 Elsevier Science B.V. Fil: Rodriguez, Georgina Emma. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia ; Argentina Fil: Schneider, Patricia Graciela. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia ; Argentina |
description |
Calcitonin (CT) is a peptide produced by the thyroid gland, whose best described role is to prevent bone reabsorption, though it also participates in other biological functions through both central and peripheral mechanisms. CT is able to inhibit brain Na+, K+-ATPase activity (Rodriguez de Lores Arnaiz, Lopez Ordieres, Peptides 1997;18:613-5) and a relationship between such enzyme activity and cholinergic function has been suggested. Accordingly, we tested CT effect on [3H]-quinuclidinyl benzilate ([3H]-QNB) binding to rat CNS membranes to determine whether the peptide is able to modify the cholinergic muscarinic receptor as well. It was found that 1x10-7-1x10-5 M CT decreased 20-70% ligand binding to hippocampal, cerebellar, cortical and striatal membranes. Scatchard analysis of saturation curves showed that 5x10-6 M CT significantly modified binding kinetic constants, thus it increased roughly 220% Kd values and decreased 20-36% Bmax values in cerebral cortical and cerebellar membranes. Since the peptide decreases affinity ligand binding and reduces the number of binding sites, CT may well be acting as a cholinergic modulator through a decrease in muscarinic receptor functionality. © 2000 Elsevier Science B.V. |
publishDate |
2000 |
dc.date.none.fl_str_mv |
2000-03 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/39154 Rodriguez, Georgina Emma; Schneider, Patricia Graciela; Calcitonin modifies ligand binding to muscarinic receptor in CNS membranes; Elsevier Science; Regulatory Peptides; 88; 1-3; 3-2000; 21-26 0167-0115 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/39154 |
identifier_str_mv |
Rodriguez, Georgina Emma; Schneider, Patricia Graciela; Calcitonin modifies ligand binding to muscarinic receptor in CNS membranes; Elsevier Science; Regulatory Peptides; 88; 1-3; 3-2000; 21-26 0167-0115 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1016/S0167-0115(99)00109-3 info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0167011599001093 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier Science |
publisher.none.fl_str_mv |
Elsevier Science |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844614350780760064 |
score |
13.070432 |